Telix Pharmaceuticals Ltd Grand Pharma Investor Webinar Transcript
Good morning, everybody, and welcome to all of the audience. We are coming to you from Singapore. I'd like to extend a very warm welcome on behalf of Telix Leadership and the China Grand Pharma Leadership to this morning's investor webinar on the opportunity for radiopharmaceuticals in China.
Just a couple of messages I've been asked to pass on before we start. First of all, questions, we will hold till the end. And those who would like to ask a question can file a DM to the moderator, which is available down the bottom of the screen. And secondly, those who are listening in, who are native Chinese speakers or Mandarin speakers, there is a separate channel, which is accessible at the bottom of the Zoom screen as well.
Please read our -- next slide, please read our respective company disclaimers. Next slide, I think today, we have a very interesting agenda for the event. I'll introduce the co-speakers in a moment. We're going to start by just reviewing the Telix-Grand Pharma partnership, which is now 2.5 years mature. We
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |